Schrodinger’s Karen Akinsanya, therapeutics R&D head, disposes of USD 928,770 common shares
SDGR•Karen Akinsanya exercises options and sells shares
Schrodinger President Karen Akinsanya exercised stock options for 31,599 shares at $4.34 on Sept. 17, 2026.
She sold 31,599 shares the same day, including 10,000 at $28 and 21,599 at $30.
Her directly held common stock position fell to 69,956 shares following the transactions.
